All Peter Madrid articles
-
NewsSRI spins off AI-powered drug discovery platform Synfini, Inc
SRI International has announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.
